Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Nidal Al Deek

Plastic and Reconstructive Surgery Cleveland, OH Medical Doctor

NPI 1114666369 CMS profile 11325962

11100 Euclid Ave, Cleveland, OH 44106

Open in the dashboard

General payments

$1,246

18 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nidal Al Deek of Cleveland, OH is reported in the CMS Open Payments database as having received $1,246 across 18 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 36th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $604 10
2024 General $253 4
2023 General $390 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nidal Al Deek
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Nidal Al Deek were reported at $604. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Nidal Al Deek Plastic and Reconstructive Surgery median Middle half National median
2019 $0 $335 $121–$1,264 $163
2020 $0 $162 $57–$417 $114
2021 $0 $245 $89–$735 $132
2022 $0 $325 $120–$932 $149
2023 $390 $343 $129–$999 $160
2024 $253 $390 $141–$1,085 $164
2025 $604 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Kerecis Limited $349 2 payments
  2. Stryker Corporation $206 2 payments
  3. Organogenesis Inc. $179 2 payments
  4. Integra LifeSciences Corporation $128 2 payments
  5. Avita Medical Americas, LLC $106 1 payment
  6. Solventum Corporation $83 1 payment
  7. Mentor Worldwide LLC $63 2 payments
  8. Aroa Biosurgery Incorporated $41 2 payments
  9. Ethicon US, LLC $33 1 payment
  10. Motiva USA, LLC $20 1 payment
  11. Other $38 2 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $1,246 18 payments
Products named General payments · program years 2023–2025
  1. Kerecis Omega3 SurgiClose Wound Care $349 2 payments
  2. Kerecis Omega3 GraftGuide $349 2 payments
  3. Kerecis Omega3 SurgiClose Wound Care $349 2 payments
  4. Kerecis Omega3 Marigen $349 2 payments
  5. Kerecis Omega3 SurgiClose Wound Care $349 2 payments
  6. PURAPLY WOUND MATRIX $158 1 payment
  7. ACTISHIELD $150 1 payment
  8. Integra Recon-Skin And Wound $128 2 payments
  9. Integra Recon-Skin And Wound $128 2 payments
  10. Integra Recon-Skin And Wound $128 2 payments
  11. Other $971 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$45,082

Medicare's payments for the services billed

Medicare patients

56

Average age 69

Services billed

195

33 women, 23 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 63%
Diabetes 43%
Chronic kidney disease 39%
Depression 39%
Ischemic heart disease 38%
COPD 29%
Cancer 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

18 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record